Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 132 for Epilepsy

Edit search filters
  1. Study of the Incidence of Electrographic Status Epilepticus and Seizures of PICU Patients at National Children’s Hospital in Hanoi, Vietnam.

    Rochester, MN

  2. Study Evaluating the Safety and Efficacy of Rap-219 in Adult Participants With Refractory Focal Epilepsy

    Rochester, MN

  3. 7T MR Imaging in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

    Scottsdale/Phoenix, AZ

  4. FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

    Scottsdale/Phoenix, AZ

  5. Allogenic Adipose-Derived Mesenchymal Stem Cells For Epilepsy During Deep Brain Stimulation Surgery

    Jacksonville, FL

  6. Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

    Rochester, MN

  7. A Study to Investigate the Effectiveness and Safety of Cannabidiol in Children and Young Adults with Dravet Syndrome

    Rochester, MN

  8. A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome

    Rochester, MN

  9. Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

    Rochester, MN

  10. A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

    Rochester, MN

.

Mayo Clinic Footer